SCHEMBL8923445

SCHEMBL8923445

C[C@H]([C@H]1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1)N(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.53
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
KDM4E B2RXH2 6/20 0.50
ALDH1A1 P00352 6/20 0.50
HPGD P15428 5/20 0.50
HSD17B10 Q99714 5/20 0.50
MAPT P10636 1/20 0.48
EPHA2 P29317 1/20 0.47
FLT4 P35916 1/20 0.47
GSK3B P49841 1/20 0.47
RARB P10826 1/20 0.47
TBXAS1 P24557 1/20 0.47
SLC6A3 Q01959 1/20 0.47
TOP1 P11387 4/20 0.47
KCNH2 Q12809 3/20 0.46
CYP1A2 P05177 1/20 0.46
TOP2A P11388 1/20 0.46
CYP2C9 P11712 1/20 0.46
TOP2B Q02880 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8925694 1.00 LMNA (0.53) LMNAKMT2AMEN1KDM4EALDH1A1
SCHEMBL8923437 1.00 LMNA (0.53) LMNAKMT2AMEN1KDM4EALDH1A1
SCHEMBL8925482 1.00 LMNA (0.53) LMNAKMT2AMEN1KDM4EALDH1A1
SCHEMBL9715606 1.00 LMNA (0.53) LMNAKMT2AMEN1KDM4EALDH1A1
SCHEMBL8925611 0.91 KMT2A (0.56) LMNAKMT2AMEN1KDM4EALDH1A1
SCHEMBL8925740 0.91 KMT2A (0.56) LMNAKMT2AMEN1KDM4EALDH1A1
SCHEMBL8925616 0.91 KMT2A (0.56) LMNAKMT2AMEN1KDM4EALDH1A1
SCHEMBL8926571 0.91 KMT2A (0.56) LMNAKMT2AMEN1KDM4EALDH1A1
SCHEMBL8924295 0.88 LMNA (0.53) LMNAKMT2AMEN1KDM4EALDH1A1
SCHEMBL8923609 0.88 LMNA (0.53) LMNAKMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559774-A1 INDIVIDUAL STEREOISOMERS OF 7- 3-(1-AMINOALKYL)-1-PYRROLIDINYL]-QUINOLONES AND NAPHTHYRIDONES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1993-09-15 EP claimed
WO-1992009596-A1 INDIVIDUAL STEREOISOMERS OF 7-[3-(1-AMINOALKYL)-1-PYRROLIDINYL]-QUINOLONES AND NAPHTHYRIDONES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1992-06-11 WO claimed
US-5633264-A Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-Quinolones and naphthyridones as antibacterial agents WARNER-LAMBERT COMPANY (US) 1997-05-27 US disclosed
US-5563155-A QUINOLONE ANTIBIOTICS WITH INCREASED EFFICACY, REDUCED SIDE EFFECTS WARNER-LAMBERT COMPANY (US) 1996-10-08 US disclosed
US-5461165-A Individual stereoisomers of intermediates of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents WARNER-LAMBERT COMPANY (US) 1995-10-24 US disclosed
US-5344940-A Bactericides WARNER-LAMBERT COMPANY (US) 1994-09-06 US disclosed
US-5258528-A Bactericides WARNER-LAMBERT COMPANY (US) 1993-11-02 US disclosed
EP-0559774-A1 INDIVIDUAL STEREOISOMERS OF 7- 3-(1-AMINOALKYL)-1-PYRROLIDINYL]-QUINOLONES AND NAPHTHYRIDONES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1993-09-15 EP disclosed
WO-1992009596-A1 INDIVIDUAL STEREOISOMERS OF 7-[3-(1-AMINOALKYL)-1-PYRROLIDINYL]-QUINOLONES AND NAPHTHYRIDONES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1992-06-11 WO disclosed